Tatsugami, Katsunori
Oya, Mototsugu
Kabu, Koki
Akaza, Hideyuki
Article History
Received: 20 December 2017
Revised: 3 April 2018
Accepted: 27 April 2018
First Online: 12 June 2018
Competing interests:
: K.K. is an employee of Bayer Yakuhin, Ltd. The remaining authors declare that they have no conflict of interest.
: The data that support the findings of this study are available from the corresponding author upon reasonable request.
: On the basis of an instruction from the Pharmaceutical and Medical Devices Agency (PMDA) which is working together with Ministry of Health, Labour and Welfare in Japan, these data were collected and analysed. This study was performed in accordance with the Declaration of Helsinki.
: Written informed consents were obtained from the patients.
: There was no individual person’s data in any form (including individual details, images or videos). All authors agree to its submission to the British Journal of Cancer and, if accepted, to its publication in this journal. We warrant that this article is original, does not infringe on any copyright or other proprietary right of any third party, is not under consideration by another journal and has not been previously published.